Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhufengshengao is a Chinese biotechnology company specializing in the research, development, and industrialization of recombinant humanized collagen through synthetic biology. Utilizing advanced yeast-based expression systems, the company produces high-purity collagen types I and III for applications in medical aesthetics, wound management, and functional skincare. Their technology focuses on achieving high biocompatibility and biological activity, positioning them as a key player in the biomaterials sector. The company operates facilities in Beijing and Tibet, integrating R&D with large-scale manufacturing. Zhufengshengao's portfolio includes Class III medical devices and bioactive ingredients used by various healthcare and cosmetic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhufengshengao.